What does ACT CAPITAL MANAGEMENT, LLC hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

ACT CAPITAL MANAGEMENT, LLC filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

KRYSTAL BIOTECH INC

$16M60K12.3%

CHEVRON CORP

$16M75K12.2%

EXXON MOBIL CORP

$12M70K9.3%

CELCUITY INC

$10M92K8.2%

TG THERAPEUTICS INC

$8M249K6.5%

ABIVAX SA

$8M71K6.2%

AMAZON.COM INC

$7M33K5.4%

VIKING THERAPEUTICS INC

$7M209K5.4%

ARROWHEAD PHARMACEUTICALS INC

$5M83K4.1%

NEKTAR THERAPEUTICS

$5M71K4.0%

Filing history loading…